Bionik Laboratories Corp. engages in the provision of rehabilitation and mobility solutions to individuals with neurological disorders. The company is headquartered in Watertown, Massachusetts and currently employs 12 full-time employees. The company went IPO on 2012-06-12. Its product portfolio includes three InMotion Robots for rehabilitation following stroke and other neurological conditions and four products in varying stages of development. The InMotion robots offer patient-adaptive therapy, intended to restore upper-extremity motor control for a range of neurological conditions and recovery stages, including early recovery from acute stroke. InMotion Robots also provide objective evaluation assessments intended to measure and report the patient’s level of motor impairment and progress during therapy. Its solutions include InMotion Therapy, InMotion ARM, InMotion ARM/HAND, InMotion EVAL, InMotion Connect, InMotion for Physical Therapy, and InMotion for Occupational Therapy. InMotion Robotics provides the occupational therapist with a range of useful protocols designed to reduce many types of upper extremity neurological impairments.
Follow-Up Questions
Qui est le CEO de Bionik Laboratories Corp ?
Mr. Richard Russo est le President de Bionik Laboratories Corp, il a rejoint l'entreprise depuis 2020.
Quelle est la performance du prix de l'action BNKL ?
Le prix actuel de BNKL est de $0, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Bionik Laboratories Corp ?
Bionik Laboratories Corp appartient à l'industrie Health Care et le secteur est Health Care
Quelle est la capitalisation boursière de Bionik Laboratories Corp ?
La capitalisation boursière actuelle de Bionik Laboratories Corp est de $0
